Thyroglobulin Antibodies and Tumor Epitope-Specific Cellular Immunity in Papillary Thyroid Cancer
Authors:
- 15 April 2024
- journal article
- research article
- Published by Georg Thieme Verlag KG in Hormone and Metabolic Research
- Vol. 56 (06) , 424-428
Abstract
Papillary thyroid carcinoma (PTC) is characterized by T cell infiltration and frequently by the presence of anti-thyroglobulin antibodies (TgAbs). The role of cellular immunity and of TbAbs in this context is a matter of debate. The aim of our study was to correlate the presence of TgAbs, tumor epitope-specific T cells and the clinical outcome of PTC patients. We studied n=183 consecutive patients with a diagnosis of PTC which were treated with total thyroidectomy plus 131I ablation. During a follow-up of in mean 97 months, most of the PTC patients had no signs of tumor relapse (n=157 patients). In contrast, one patient had serum Tg levels above the detection limit and<1 ng/ml, two patients Tg serum levels≥1 ng/ml and<2 ng/ml and n=23 patients had Tg serum levels≥2 ng/ml. Morphological signs of tumor recurrence were seen in 14 patients; all of these patients had serum Tg levels≥2 ng/ml. Importantly, with the exception of one patient, all TgAb positive PTC patients (n=27) had no signs of tumor recurrence as the serum Tg levels were below the assays functional sensitivities. Tetramer analyses revealed a higher number of tumor epitope-specific CD8+T cells in TgAb positive patients compared to TgAb negative PTC patients. In summary, we show that the occurrence of TgAbs may have an impact on the clinical outcome in PTC patients. This might be due to a tumor epitope-specific cellular immunity in PTC patients. Received: 14 February 2024 Accepted: 26 February 2024 Article published online: 15 April 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, GermanyKeywords
This publication has 37 references indexed in Scilit:
- Prevalence of Hashimoto Thyroiditis in Adults With Papillary Thyroid Cancer and Its Association With Cancer Recurrence and OutcomesJAMA Network Open, 2021
- The value of preoperative antithyroidperoxidase antibody as a novel predictor of recurrence in papillary thyroid carcinomaInternational Journal of Cancer, 2018
- Chronic lymphocytic thyroiditis (CLT) has a positive prognostic value in papillary thyroid cancer (PTC) patients: the potential key role of Foxp3+ T lymphocytesJournal of Endocrinological Investigation, 2017
- Prognostic value of change in anti-thyroglobulin antibodies after thyroidectomy in patients with papillary thyroid carcinomaClinical and Translational Oncology, 2017
- Chronic lymphocytic thyroiditis does not influence the risk of recurrence in patients with papillary thyroid carcinoma and excellent response to initial therapyEndocrine, 2016
- Hashimoto's thyroiditis and papillary thyroid cancer: are they immunologically linked?Trends in Endocrinology & Metabolism, 2014
- Thyroid cancer mortality and incidence: A global overviewInternational Journal of Cancer, 2014
- Coexistence of papillary thyroid cancer with Hashimoto thyroiditisLangenbeck's Archives of Surgery, 2012
- Coexisting Chronic Lymphocytic Thyroiditis and Papillary Thyroid Cancer RevisitedWorld Journal of Surgery, 2001
- RELATION OF THYROID NEOPLASMS TO HASHIMOTO DISEASE OF THE THYROID GLANDArchives of Surgery, 1955